The Research and Innovations Actions (RIA) are one of the key features of Horizon Europe and come with their own set of provisions and funding rates.
|Max. funding amount||Project duration||Deadline|
|None — unless specified in the call||None — unless specified in the call||None — unless specified in the call|
Scope of the project
Funding available for collaborative research projects tackling clearly defined challenges which can lead to the development of new knowledge or new technology.
RIA includes basic and applied research, technology development and integration, testing and validation on a small-scale prototype in a laboratory or simulated environment. Projects may contain closely connected but limited demonstration or pilot activities aiming to show technical feasibility in a near to operational environment. Funding for these types of activities is typically 100%.
Consortia of partners from different countries, industry, and academia. At least 3 partners from 3 different European (or associated) countries.
Research and Innovations Actions are collaborative projects funding research activities relatively upstream of a commercial product. They allow the exploration of new technologies, new methods, new products, or improvements to existing ones.
These projects may include fundamental or applied research, but also development and new technology implementation, either at the lab scale or in a simulated environment close to the final one.
Technology Readiness Level (TRL) required for the RIA calls is usually relatively low (below 6), meaning that the expected outcome of the project is a functional prototype.
Note: The acronym “RIA” describes the type of funding, but it is not a type of call. Several types of European calls are actually RIA (for example SC1, IMI, EIC Pathfinder, etc.)
One step closer to implementation of an extensive DNA test by ttopstart’s partner HMF
One step closer to implementation of an extensive DNA test by ttopstart’s partner HMFLast week Nature published the paper “Pan-cancer whole genome analyses of metastatic solid tumors”. In this study, a team of leading Dutch scientists have created, for the first time,...